AIS's Health Business Daily is a daily email newsletter with strategic business stories written by experienced AIS Health reporters, as well as other information of interest to health care business leaders — including news from the nation’s leading health insurers, developments from the federal and state governments that impact the health care industry, and exclusive datapoints from Subscribe now to get an issue delivered to your inbox every morning!
January 25, 2018
Today's Featured Story
Follow-on Biologic Basaglar Shakes Up the Insulin Market
Reprinted from DRUG BENEFIT NEWS
A year after the first follow-on biologic Basaglar (insulin glargine) from Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals, Inc. launched in the U.S. diabetes market, access to the drug among payers is growing rapidly, with half of all U.S. formularies placing it on their first or second tier. Although Basaglar has delivered modest savings compared to the originator drug, payers may see deeper discounts once other follow-on biologics like Merck & Co., Inc.’s Lusdana hit the insulin market....  Read Full Story
Subscribe to AIS Health's Drug Benefit News

Today's AIS Health Datapoint
1,307,252 people are enrolled in health plans in Idaho — about 78% of the state’s population. Gov. Butch Otter (R) issued an executive order in January to allow health insurance carriers to offer products that don’t meet ACA benefit requirements.

People on the Move

The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Questions or suggestions about the content in AIS's HEALTH BUSINESS DAILY should be directed to Executive Editor Jill Brown at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2018 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Contact for more information.